Intercept Pharmaceuticals, Inc.

Ownership Transactions Reported by 20 Insiders

Industry
Pharmaceutical Preparations
Location
305 Madison Avenue, Morristown, NJ

There are no Buy or Sell transactions made by insiders since 11/5/2023

Intercept Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gail Cawkwell SVP, Med Affairs, Safety & PV $679K Feb 12, 2022
Bryan Ball Chief Qual. Officer & SVP Ops. $478K Jul 11, 2022
Lisa DeFrancesco SVP, IR & Corp. Affairs $196K Dec 31, 2021
Daniel Bradbury Director Nov 8, 2023
David A. Ford Chief Human Resources Officer Nov 8, 2023
Linda M. Richardson EVP & Chief Commercial Officer Nov 8, 2023
Bjorkeson Dagmar Rosa Director Nov 8, 2023
Paolo Fundaro Director Nov 8, 2023
Keith Michael Gottesdiener Director Nov 8, 2023
Srinivas Akkaraju Director Nov 8, 2023
Nancy Miller-Rich Director Nov 8, 2023
M. Michelle Berrey President, R&D and CMO Nov 8, 2023
Andrew Saik EVP & Chief Financial Officer Nov 8, 2023
Jerome Benedict Durso CEO, Director Nov 8, 2023
Rocco Venezia Chief Accounting Officer Nov 8, 2023
Jared Freedberg General Counsel Nov 8, 2023
Mark Pruzanski Director Nov 8, 2023
Luca Benatti Director Nov 8, 2023
Gino Santini Director Nov 8, 2023
Glenn Sblendorio Director Nov 8, 2023

Recent Insider Transactions by Companies or Individuals for Intercept Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.